from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2393/che1

LFCtreatmentdescriptionclass of inhibitor

-1.683

Amikacinug/mL Amikacintranslation

-1.743

Cap5-10ug/mL Capreomycintranslation

-2.296

Rox10-50 ug/mL Roxithromycintranslation

-0.047

SM2-5 ug/mL Streptomycintranslation

-2.308

Tet5-10 ug/mL Tetracyclinetranslation

-0.131

Rif0.2-5ug/mL Rifampicintranscription

0.779

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.600

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.170

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.157

CPZ10-50 ug/mL Chlorpromazinerespiration

1.004

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.098

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.445

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.559

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.417

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.531

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.298

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.392

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.406

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.176

KCN5-20 ug/mL Potassium cyaniderespiration

-0.659

NaN30.2-2 mM Sodium aziderespiration

-0.449

Nigericin50 uM Nigericinrespiration

-1.054

TRC10-150 ug/mL Triclosanrespiration

-0.514

TRZ10-25 ug/mL Thioridazinerespiration

-0.829

Valinomycin0.5-10 uM Valinomycinrespiration

0.812

ZnSO42 mM ZnSO4respiration

1.875

menadione6-10 ug/mL Menadionerespiration

0.573

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.152

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.801

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.292

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.287

NRP_1Non-replicating persistence stage 1dosRassociated

0.339

Amp0.2mg/mL AmpicillincellWall

0.097

Cephalexin20-100 ug/mL CephalexincellWall

-0.886

Cerulenin0.32-5 ug/mL CerulenincellWall

0.503

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.015

EMB10-20 ug/mL EthambutolcellWall

-0.335

Eta12-40 ug/mL EthionamidecellWall

-0.047

INH0.2-0.4 ug/mL IsoniazidcellWall

0.185

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.534

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.781

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.249

BZA0.12 mg/mL BenzamidearomaticAmides

-0.480

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.155

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.951

H2O24 mM hydrogen peroxideDNAdamaging

0.953

Levo10 ug/mL LevofloxacinDNAdamaging

-0.464

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.746

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.238

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.016

UVUV-irradiationDNAdamaging

1.335

ARP41-4 ug/mL Antitubercular compound ARP4?

0.077

Antimycin12.5-50 ug/mL Antimycin A?

0.650

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.511

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.479

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.086

PA8240.2-2 ug/mL PA-824?

-0.124

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.261

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.497

Verapamil50 uM Verapamil?

0.812

mercaptoethanol2 mM 2-Mercaptoethanol?

0.719

methoxatin10-20 ug/mL Methoxatin?